ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

摘要:

Tamoxifen [‘Nolvadex’] was the first nonsteroidal synthetic antiestrogen agent to establish a place in the treatment of patients with breast cancer. Toremifene [‘Fareston’], a relative new kid on the block, is a novel antiestrogen agent with a similar antitumour effect to tamoxifen in the treatment of advanced breast cancer. However, limited information is available about the use of toremifene as adjuvant therapy for patients with breast cancer. The European and American perspectives on the challenge posed by toremifene to tamoxifen's role as the gold standard therapy for the treatment of patients with breast cancer were outlined at the 20th Annual San Antonio Breast Cancer Symposium [Texas, US; December 1997].

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

摘要:

During the 1990s significant strides forward have been made in the treatment of patients with epilepsy. The development of new and emerging antiepileptic drugs has increased the treatment options available to clinicians. However, new therapies are still needed because seizures are not effectively controlled in about 25% of patients with epilepsy. As we approach the new millennium, the stage is set for dramatic new forms of therapy, delegates were told at the Presidential Symposium at the Annual Meeting of the American Epilepsy Society [Boston, US; December 1997].

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS